Literature DB >> 24066812

The correlation between pre-operative serum tumor markers and lymph node metastasis in gastric cancer patients undergoing curative treatment.

Fangxuan Li1, Shixia Li, Lijuan Wei, Xiaofeng Liang, Huan Zhang, Juntian Liu.   

Abstract

BACKGROUND: There was few study concentrated on the correlation between the evaluated tumor markers and lymph node metastasis. In this study, we aimed to evaluate the correlation between the CA724, CA242, CA199, CEA and the lymph node metastasis of gastric cancer and assess the prognostic value of them in different N stage patients.
METHODS: We analyzed the correlation between serum level of CA724, CA242, CA199, CEA and lymph node metastasis in 1501 gastric cancer patients.
RESULTS: Lymph node metastasis of gastric cancer was related with tumor location, Bormann type, tumor size, histological type, depth of invasion and TNM stage (p < 0.05). The values of CA724, CA242, CA199 and CEA were positively correlated with the metastatic lymph node counts and the N stage (p < 0.05). The later the N stage was, the levels of CA724, CA242 and CA199 were higher. The later the N stage was, the positive rates of tumor markers were higher (p < 0.05). In comparing with single tumor markers, the positive rates of tumor markers combination were higher. The combination of CA724 + CA242 + CA199 + CEA had highest positive rate. The higher CEA level related to N1 stage patients while higher CA199 was related with poor prognosis for N1 stage patients. For N0 and N2 stage patients, evaluation of CA724 indicated poorer prognosis. For N1 and N2 stage gastric patients, the patients with increased CA242 inclined to have shorter survival time.
CONCLUSIONS: The tumor makers CA724, CA242, CA199 and CEA were evaluated significantly in the gastric patients with later N stage. The combination of these four tumor markers maybe prefer diagnostic index of gastric cancer and its lymph node metastasis. These tumor markers can be a possible indicator of poorer prognosis in different N stage patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24066812     DOI: 10.3109/1354750X.2013.840800

Source DB:  PubMed          Journal:  Biomarkers        ISSN: 1354-750X            Impact factor:   2.658


  19 in total

1.  Clinical value of serum biomarkers CA153, CEA, and white blood cells in predicting sentinel lymph node metastasis of breast cancer.

Authors:  Yuan Fan; Xiuyuan Chen; Hongjiang Li
Journal:  Int J Clin Exp Pathol       Date:  2020-11-01

2.  Decline of serum CA724 as a probable predictive factor for tumor response during chemotherapy of advanced gastric carcinoma.

Authors:  Li Zou; Jun Qian
Journal:  Chin J Cancer Res       Date:  2014-08       Impact factor: 5.087

3.  Clinical role of circulating miR-223 as a novel biomarker in early diagnosis of cancer patients.

Authors:  Xiaoying Zhou; Guoping Ji; Han Chen; Wujuan Jin; Chengqiang Yin; Guoxin Zhang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

4.  Differences and correlation of serum CEA, CA19-9 and CA72-4 in gastric cancer.

Authors:  Junxiu Yu; Shuguang Zhang; Bingbo Zhao
Journal:  Mol Clin Oncol       Date:  2015-12-15

5.  Prognostic value of serum tumor abnormal protein in gastric cancer patients.

Authors:  Feng Lan; Ming Zhu; Qiufeng Qi; Yaping Zhang; Yongping Liu
Journal:  Mol Clin Oncol       Date:  2016-04-26

6.  The prognostic significance of pretreatment serum CEA levels in gastric cancer: a meta-analysis including 14651 patients.

Authors:  Kai Deng; Li Yang; Bing Hu; Hao Wu; Hong Zhu; Chengwei Tang
Journal:  PLoS One       Date:  2015-04-16       Impact factor: 3.240

7.  Serum fibrinogen levels are positively correlated with advanced tumor stage and poor survival in patients with gastric cancer undergoing gastrectomy: a large cohort retrospective study.

Authors:  Xuefeng Yu; Fulan Hu; Qiang Yao; Chunfeng Li; Hongfeng Zhang; Yingwei Xue
Journal:  BMC Cancer       Date:  2016-07-14       Impact factor: 4.430

Review 8.  Classic tumor markers in gastric cancer. Current standards and limitations.

Authors:  Călin Căinap; Viorica Nagy; Alexandra Gherman; Sanziana Cetean; Istvan Laszlo; Anne-Marie Constantin; Simona Căinap
Journal:  Clujul Med       Date:  2015-04-15

Review 9.  Clinicopathologic and Prognostic Value of Serum Carbohydrate Antigen 19-9 in Gastric Cancer: A Meta-Analysis.

Authors:  Yong-xi Song; Xuan-zhang Huang; Peng Gao; Jing-xu Sun; Xiao-wan Chen; Yu-chong Yang; Cong Zhang; Hong-peng Liu; Hong-chi Wang; Zhen-ning Wang
Journal:  Dis Markers       Date:  2015-10-21       Impact factor: 3.434

10.  Prognostic significance of preoperative serum CA125, CA19-9 and CEA in gastric carcinoma.

Authors:  Wei Wang; Xiao-Long Chen; Shen-Yu Zhao; Yu-Hui Xu; Wei-Han Zhang; Kai Liu; Xin-Zu Chen; Kun Yang; Bo Zhang; Zhi-Xin Chen; Jia-Ping Chen; Zong-Guang Zhou; Jian-Kun Hu
Journal:  Oncotarget       Date:  2016-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.